Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance
Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance
Recruiting · NCT06043973 · Registry updated 2023-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance | Advanced Non-small Cell Lung Cancer | Recruiting | Phase 3 | 2023-09-21 | NCT06043973 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Qianfoshan Hospital | 88 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Degan Lu | Jinan | China | 2 |